Drug major Johnson & Johnson on Wednesday raised its forecast for fiscal 2021 earnings and revenues above market view, after reporting strong growth in second-quarter results. The company's quarterly adjusted earnings and revenues also beat market estimates. In pre-market activity on the NYSE, JNJ shares were gaining around 1.22 percent to trade at $170.50.
from RTT - Earnings https://ift.tt/3zceFx8
via IFTTT
No comments:
Post a Comment